Biologic and Cell Solutions
Achieve Success with Biologic Drugs and Cell Therapies
As the healthcare system moves away from treatments that focus on the symptoms of a disease and towards curing the disorder, new technologies are necessary to achieve success. Historically the pharmaceutical industry utilized small molecules and chemicals as active ingredients in drugs, but cures require more complex entities such as cell therapies, peptides and antibodies.
Thus, novel methods to deliver these therapies are needed. Without a targeted delivery system, the chances of biological drugs or cell therapies succeeding in clinical trials is decreased.
Core-Shell Spherification® (CSS) is a platform delivery technology that coats (encapsulates) biological therapies including cells, cell clusters, peptides, scaffolds and antibodies in a hydrogel. CSS is completely unique because it can utilize hydrogels that were once thought to be unavailable for encapsulation such as hyaluronic acid and PEG-based hydrogels. These hydrogels are already successfully used in areas including wound healing, dermal fillers, and cosmetic applications.
For the first time, a delivery system is now available for the newest classes of therapies that biotech companies are developing. CSS maintains and slowly releases the biological in a target location. Tunable control over formulations allows control of factors such as microbead size, release rates, and loading densities, providing a wealth of opportunity to create successful cell-based therapeutics.
Improving Therapies for People and Pets Alike
From head and heart to cancer and beyond, our platform can improve the delivery of leading-edge therapies.
Diabetes, joint pain and lameness can be devastating for our furry friends. We can help you improve therapies and outcomes for them.